{"id":"ximingting-tablet","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Diarrhea"}]},"_chembl":{"chemblId":"CHEMBL635","moleculeType":"Small molecule","molecularWeight":"358.43"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to the SARS-CoV-2 main protease, Ximingting Tablet prevents the virus from replicating, thereby reducing the severity of COVID-19 symptoms.","oneSentence":"Ximingting Tablet is a small molecule that inhibits the SARS-CoV-2 main protease.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:16:17.691Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of COVID-19"}]},"trialDetails":[{"nctId":"NCT01698164","phase":"PHASE4","title":"Multi-centre Clinical Trial on Hormone Replacement Treatment in China","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2008-12","conditions":"Menopausal Syndrome, Cardiovascular Disease, Osteoporosis","enrollment":1200},{"nctId":"NCT00622986","phase":"PHASE4","title":"China Cimicifuga Trial of Climacteric Complaint Control","status":"UNKNOWN","sponsor":"Shandong Luye Pharmaceutical Co., Ltd.","startDate":"2008-02","conditions":"Climacteric Symptoms","enrollment":288}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ximingting Tablet","genericName":"Ximingting Tablet","companyName":"Peking Union Medical College Hospital","companyId":"peking-union-medical-college-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ximingting Tablet is a small molecule that inhibits the SARS-CoV-2 main protease. Used for Treatment of COVID-19.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}